Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pediatrix Medical Group, Inc.MD · Entity 4451 | Principal Accounting Officer | November 10, 2021 | November 10, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pediatrix Medical Group, Inc.
Report date November 10, 2021 · Filed November 10, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 96,666 |
Reported balance
After 2021-11-10 transaction · row 1
1 source rowRow 1 · 2021-11-10 · Sale · Disposed 5,000 · Balance 96,666 F1: Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 13, 2021. F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $28.36 to $28.55 for a weighted average sales price of $28.45. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 13, 2021.
F2: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $28.36 to $28.55 for a weighted average sales price of $28.45. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2021 Filed Nov 10, 2021 21:05 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 5,000 | $28.45 | $142,250.00 |
DisclosureSEC source: 0001209191-21-063832 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,666 F1 · kind: Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 13, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $28.36 to $28.55 for a weighted average sales price of $28.45. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 20:46 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 9,238 | $26.87 | $248,225.06 |
DisclosureSEC source: 0001209191-21-062083 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,666 F1 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.83 to $26.94 for a weighted average sales price of $26.87. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 61 shares acquired by the reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filing. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:13 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 10,000 | $31.83 | $318,300.00 |
DisclosureSEC source: 0001209191-21-054746 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,843 F1 · price: The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $31.63 to $31.92 for a weighted average sales price of $31.83. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 58 shares acquired by the reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filed. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:20 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 7,858 | $31.98 | $251,298.84 |
DisclosureSEC source: 0001209191-21-037166 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,785 F1 · kind: Represents 7,858 shares withheld for payment of taxes upon vesting of shares previously reported. F2 · balance_after: Includes 70 shares acquired by reporting person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:45 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 2,568 | $24.43 | $62,736.24 |
DisclosureSEC source: 0001209191-21-016912 · doc4.xml · nonDerivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,573 F3 · kind: Represents 2,568 shares withheld for payment of taxes upon vesting of shares previously reported. F4 · balance_after: Includes 283 shares acquired by Reporting person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:45 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 10,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016912 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,858 F2 · kind: Restricted shares granted pursuant to the Issuer's Plan, in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2022, twenty-five percent (25%) of the restricted shares will vest on March 1, 2023 and fifty percent (50%) of the restricted shares will vest on March 1, 2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:45 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 10,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-016912 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,653 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 5,102 additional shares based on the achievement of certain performance-based criteria for the twelve months ending December 31, 2021. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three installments of twenty-five percent (25%) on March 1, 2022, twenty-five percent (25%) on March 1, 2023 and fifty percent (50%) on March 1, 2024, subject to the terms of the Plan. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 20:28 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 329 | $15.53 | $5,109.37 |
DisclosureSEC source: 0001209191-20-034023 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,449 F1 · kind: Represents 329 shares withheld for payment of taxes upon vesting of shares previously reported. F2 · kind: Includes 163 shares acquired by Reporting Person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing. F2 · balance_after: Includes 163 shares acquired by Reporting Person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:52 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionRestricted Shares Units · Derivative | 7,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015322 · doc4.xml · derivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,862 shares Expires 2027-12-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Restricted Shares Units granted under the Issuer's 2008 Incentive Compensation Plan. F4 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock. F5 · derivative.exercise_date: Restricted Shares Units became payable in shares of Issuer's Common Stock and vested after satisfaction of certain performance based criteria. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:52 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Tax withholdingCommon Stock | 3,023 | $17.09 | $51,663.07 |
DisclosureSEC source: 0001209191-20-015322 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,615 F2 · kind: Represents 3,023 shares withheld for payment of taxes upon vesting of shares previously reported. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:52 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 7,862 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-015322 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Shares Units that converted into shares of the Issuer's Common Stock on a one-for-one basis upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 23:07 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 18,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010332 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,776 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 4,624 additional shares based on the achievement of certain performance-based criteria for the twelve months ended December 31, 2020. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on March 1, 2021, March 1, 2022 and March 1, 2023, subject to the terms of the Plan. F2 · balance_after: Includes 520 shares acquired by Reporting Person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:56 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 50,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-034374 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,758 F1 · kind: Restricted shares will vest in two equal installments on June 1, 2021 and June 1, 2022. F2 · balance_after: Includes 191 shares acquired by Reporting Person through Issuer's Employee Stock Purchase Plan since the last Form 4 filing. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:38 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 7,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-010208 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,877 F1 · kind: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance-based criteria with any shares earned vesting in three equal installments on March 1, 2020, March 1, 2021 and March 1, 2022. F2 · balance_after: Includes 41 shares that were acquired by Reporting person through Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 22, 2019 Filed Jan 23, 2019 21:46 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 2,500 | $36.60 | $91,500.00 |
DisclosureSEC source: 0001209191-19-004981 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,583 F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 sales plan. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 20:45 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 1,025 | $48.20 | $49,405.00 |
DisclosureSEC source: 0001209191-18-046822 · doc4.xml · nonDerivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,583 Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 20:45 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 1,540 | $48.18 | $74,197.20 |
DisclosureSEC source: 0001209191-18-046822 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,608 Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 20:45 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 935 | $48.17 | $45,038.95 |
DisclosureSEC source: 0001209191-18-046822 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,148 Read SEC document |
| June 12, 2018 Filed Jun 13, 2018 20:58 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 6,516 | $46.56 | $303,373.88 |
DisclosureSEC source: 0001209191-18-037509 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,083 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-three (23) separate transactions with prices ranging from $46.28 to $46.70 for an average weighted sales price of $46.5583. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this section. F2 · balance_after: Includes 883 shares that were acquired by Reporting person through Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:56 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $27.72 Strike: $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-18-032649 · doc4.xml · derivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:56 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 3,000 | $46.43 | $139,290.00 |
DisclosureSEC source: 0001209191-18-032649 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,716 F1 · kind: Sales made pursuant to Reporting Person's 105b-1 trading plan. Read SEC document |
| May 22, 2018 Filed May 23, 2018 20:56 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 3,000 | $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-18-032649 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:05 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $27.72 Strike: $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-18-019619 · doc4.xml · derivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:05 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 3,000 | $58.35 | $175,062.60 |
DisclosureSEC source: 0001209191-18-019619 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,716 F1 · kind: Sales made pursuant to Reporting Person's 105b-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in sixteen (16) separate transactions with prices ranging from $57.85 to $58.79 for a weighted average sales price of $58.3542. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares at each separate price within the range set forth in this footnote. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 21:05 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 3,000 | $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-18-019619 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 2, 2018 22:06 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 4,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-015797 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,716 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance-based criteria with any shares earned vesting in three equal installments on March 1, 2019, March 1, 2020 and March 1, 2021. Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 21:48 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $27.72 Strike: $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-17-065215 · doc4.xml · derivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 3,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 21:48 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 3,000 | $51.58 | $154,740.00 |
DisclosureSEC source: 0001209191-17-065215 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 Read SEC document |
| December 12, 2017 Filed Dec 12, 2017 21:48 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 3,000 | $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-17-065215 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 22:34 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantRestricted Shares Units · Derivative | 7,862 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-064790 · doc4.xml · derivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,862 Underlying: Common Stock · 7,862 shares Expires 2020-05-15 F1 · security: Restricted Shares Units, or Deferred Stock, granted under the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended. F2 · derivative.exercise_price: Each Restricted Share Unit represents the equivalent of one share of Issuer's Common Stock. F3 · derivative.exercise_date: Restricted Shares Units become payable in shares of Issuer's Common Stock and will vest after satisfaction of certain performance-based and time-based criteria. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:11 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $27.72 Strike: $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-17-052647 · doc4.xml · derivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 3,000 shares Expires 2018-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:11 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 3,000 | $42.85 | $128,550.00 |
DisclosureSEC source: 0001209191-17-052647 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 Read SEC document |
| September 12, 2017 Filed Sep 13, 2017 21:11 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 3,000 | $27.72 | $83,145.00 |
DisclosureSEC source: 0001209191-17-052647 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,569 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 20:44 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | GrantCommon Stock | 4,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-037325 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,500 | $28.55 Strike: $28.55 | $71,362.50 |
DisclosureSEC source: 0001209191-17-012120 · doc4.xml · derivative · entry 4 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 1,500 | $69.58 | $104,371.50 |
DisclosureSEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 3 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,525 F1 · balance_after: Includes 9,143 shares that were acquired by Reporting Person through Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | SaleCommon Stock | 1,000 | $69.58 | $69,581.20 |
DisclosureSEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 2 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,025 Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:31 UTC | Pediatrix Medical Group, Inc. MD · Entity 4451 | Exercise / conversionCommon Stock | 2,500 | $28.55 | $71,362.50 |
DisclosureSEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 1 Pepia John C · CIK 0001674717 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.